PT  - JOURNAL ARTICLE
AU  - Simwanza, John
AU  - Hines, Jonas Z.
AU  - Sinyange, Danny
AU  - Sinyange, Nyambe
AU  - Mulenga, Chilufya
AU  - Hanyinza, Sarah
AU  - Sakubita, Patrick
AU  - Langa, Nelia
AU  - Nowa, Haggai
AU  - Gardner, Priscilla
AU  - Saasa, Ngonda
AU  - Chipeta, Gabriel
AU  - Simpungwe, James
AU  - Malambo, Warren
AU  - Hamainza, Busiku
AU  - Kapata, Nathan
AU  - Kapina, Muzala
AU  - Musonda, Kunda
AU  - Liwewe, Mazyanga
AU  - Mwale, Consity
AU  - Fwoloshi, Sombo
AU  - Mulenga, Lloyd B.
AU  - Agolory, Simon
AU  - Mukonka, Victor
AU  - Chilengi, Roma
TI  - COVID-19 vaccine effectiveness during a prison outbreak when the Omicron was the dominant circulating variant— Zambia, December 2021
AID  - 10.1101/2022.05.06.22274701
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.05.06.22274701
4099  - http://medrxiv.org/content/early/2022/06/08/2022.05.06.22274701.short
4100  - http://medrxiv.org/content/early/2022/06/08/2022.05.06.22274701.full
AB  - During a COVID-19 outbreak in a prison in Zambia from 14th to 19th December 2021, a case control study was done to measure vaccine effectiveness (VE) against infection and symptomatic infection, when the Omicron variant was the dominant circulating variant. Among 382 participants, 74.1% were fully vaccinated and the median time since full vaccination was 54 days. There were no hospitalizations or deaths. COVID-19 VE against any SARS-CoV-2 infection was 64.8% and VE against symptomatic SARS-CoV-2 infection was 72.9%. COVID-19 vaccination helped protect incarcerated persons against SARS-CoV-2 infection during an outbreak while Omicron was the dominant variant in Zambia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Excellence in Research Ethics Science converge Zambia gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript